Abstract Several experimental therapeutics have been demonstrated to be safe and effective in animal models of neurological disorders, but have failed when they reached the clinic. Postulated factors that affected the poor clinical outcomes include the lack of proper treatment controls and clinically relevant animal models. This failure of lab-to-clinic translation has plagued many neuroprotective drugs for stroke. With this in mind, the stem cell therapy field has cautiously approached translating stem cell products for clinical application, in that a negative clinical trial may hinder the entire regenerative medicine therapeutics. Here, we discuss the many translational challenges associated with stem cell therapy in the setting of stroke.
stem cell therapy   1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Stem-cell_therapy     

clinical trial                1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Clinical_trial        

stroke                        1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Stroke                

drugs                         0.8136655358185161^^http://www.w3.org/2001/XMLSchema#double           http://dbpedia.org/resource/Pharmaceutical_drug   

neurological disorders        0.9926770879373227^^http://www.w3.org/2001/XMLSchema#double           http://dbpedia.org/resource/Neurological_disorder 

regenerative medicine         0.9999922465946601^^http://www.w3.org/2001/XMLSchema#double           http://dbpedia.org/resource/Stem-cell_therapy     

translation                   0.8617859412434311^^http://www.w3.org/2001/XMLSchema#double           http://dbpedia.org/resource/Translation_(biology) 

neuroprotective               1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Neuroprotection       

stroke                        1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Stroke                

animal models                 0.9999999903724301^^http://www.w3.org/2001/XMLSchema#double           http://dbpedia.org/resource/Animal_model          

hinder                        0.99999987526622^^http://www.w3.org/2001/XMLSchema#double             http://dbpedia.org/resource/Hinder                

stem cell                     0.9999626095354675^^http://www.w3.org/2001/XMLSchema#double           http://dbpedia.org/resource/Stem-cell_therapy     

therapeutics                  0.9999999999856755^^http://www.w3.org/2001/XMLSchema#double           http://dbpedia.org/resource/Therapy               

animal models                 0.9999999903724301^^http://www.w3.org/2001/XMLSchema#double           http://dbpedia.org/resource/Animal_model          

therapeutics                  0.9999999999856755^^http://www.w3.org/2001/XMLSchema#double           http://dbpedia.org/resource/Therapy               

stem cell therapy             1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Stem-cell_therapy     

